Besides XRCC1, other DNA base excision repair genes including OGG1, [17] APE1, [17, 39–41] XRCC3, [42] PARP1, [43] were reported to be associated with clinical outcomes in NSCLC treated with platinum-based regimen. Here, PARP1 is linked to non-small cell lung carcinoma.